Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a Texas site to the Locations; updated the page revision to v3.3.3 and removed the previous Texas Locations reference and HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew Study Record Dates entries were added for 2025-12-03 (Actual) and 2025-12-05 (Actual), and entries for 2025-09-11/12 were removed. These changes are administrative in nature and do not affect trial details or outcomes.SummaryDifference0.3%

- Check35 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1. No changes to trial information or page content; this appears to be an internal site version update.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoval of the government funding/operating status notice from the page; core study details, eligibility criteria, endpoints, and contacts remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedAdministrative update to the study record reflecting the last update posted and QC criteria timestamp; no changes to eligibility, endpoints, enrollment, or treatment protocol. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.